Poland, Aug. 13 -- Poland based NEUCA S.A. has secured contract from Instytut "Pomnik-Centrum Zdrowia Dziecka" for Pharmaceutical products - ZP/CZD/072/26 Delivery of the medicinal product Odevixibatum used as part of the B175 drug program . The value of the contract is worth 15677038.5 PLN .
Published by HT Digital Content Services with permission from Pivotal Sources....